Turn product knowledge into a useful recommendation.
Understand the product, the audience and the offer. Explain why it may be useful and make the commission relationship clear. Eligible sales attributed to your recommendations earn commission under your participant agreement.
Noctio is our starting product. Its maintained product explanation gives you a reliable foundation for describing the experience and answering everyday questions.
Canadian launch programme
Initial participation is by invitation and agreement with FrequenSee Labs. Participants must be based in Canada and able to receive Interac e-Transfer into a Canadian bank account. Contact us to discuss participation.
Customer markets are separate from participant eligibility. Noctio’s intended first commerce markets are the United States, United Kingdom, Canada, Ireland and Australia, subject to store availability.
Clear reporting and payment terms
Your participant agreement will specify the commission rate and calculation basis, sales attribution rules, treatment of refunds and payment schedule. The initial Canadian programme uses Interac e-Transfer for commission payments.
Commission statements should make eligible sales and adjustments understandable. Questions about attribution or payment have a direct route to FrequenSee. Participation terms are agreed before promotional activity begins.
Protect the value of your recommendation.
Recommend Noctio accurately and disclose the commercial relationship. Personal experience can help someone make a decision; medical claims and guaranteed sleep outcomes are outside the product’s offer.
Commission is earned from eligible product sales. Recruitment does not earn commission, and income depends on sales rather than participation alone.
Discuss participation.
Tell us about the audience you understand, your interest in Noctio and how you would introduce the product. We will discuss programme fit and the terms that would apply.
Enquire about participation